5.15

5.15 (-1.85%)

As of Jun 14, 2022

FORMA THERAPEUTICS HOLDINGS, INC. [FMTX]

Source: 

Company Overview

We are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers. Our drug discovery expertise has generated a pipeline of product candidates focused on indications with significant unmet patient need. Our pipeline consists of six product candidates, two of which we are pursuing as product candidates for development, FT-4202 for the treatment of sickle cell disease, or SCD, and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer, or mCRPC.

CountryUS
Headquarterswatertownmassachusetts
Phone Number(617) 679-1970
Industrybiological products (no diagnostic substances)
CEOFrank D. Lee
Websiteformatherapeutics.com